Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab
Clinical trial NCT05568212 · RECRUITING
Trial details
- NCT number
- NCT05568212
- Sponsor
- Fondazione Ricerca Traslazionale
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-02
- Primary completion
- 2026-05-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.